These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 19126296

  • 1. Effects of cytochrome P450 inducers and inhibitors on the pharmacokinetics of intravenous furosemide in rats: involvement of CYP2C11, 2E1, 3A1 and 3A2 in furosemide metabolism.
    Yang KH, Choi YH, Lee U, Lee JH, Lee MG.
    J Pharm Pharmacol; 2009 Jan; 61(1):47-54. PubMed ID: 19126296
    [Abstract] [Full Text] [Related]

  • 2. Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous omeprazole in rats.
    Lee DY, Shin HS, Bae SK, Lee MG.
    Biopharm Drug Dispos; 2006 Jul; 27(5):209-18. PubMed ID: 16586464
    [Abstract] [Full Text] [Related]

  • 3. Effects of enzyme inducers and inhibitors on the pharmacokinetics of metformin in rats: involvement of CYP2C11, 2D1 and 3A1/2 for the metabolism of metformin.
    Choi YH, Lee MG.
    Br J Pharmacol; 2006 Oct; 149(4):424-30. PubMed ID: 16940989
    [Abstract] [Full Text] [Related]

  • 4. Effects of CYP inducers and inhibitors on the pharmacokinetics of intravenous theophylline in rats: involvement of CYP1A1/2 in the formation of 1,3-DMU.
    Yang KH, Lee JH, Lee MG.
    J Pharm Pharmacol; 2008 Jan; 60(1):45-53. PubMed ID: 18088504
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of cytochrome P450 (CYP) inducers and inhibitors on ondansetron pharmacokinetics in rats: involvement of hepatic CYP2D subfamily and 3A1/2 in ondansetron metabolism.
    Yang SH, Lee MG.
    J Pharm Pharmacol; 2008 Jul; 60(7):853-61. PubMed ID: 18549671
    [Abstract] [Full Text] [Related]

  • 8. Induction of the male-specific cytochrome P450 3A2 in female rats by phenytoin.
    Ghosal A, Sadrieh N, Reik L, Levin W, Thomas PE.
    Arch Biochem Biophys; 1996 Aug 01; 332(1):153-62. PubMed ID: 8806720
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of mirodenafil, a new erectogenic, and its metabolite, SK3541, in rats: involvement of CYP1A1/2, 2B1/2, 2D subfamily, and 3A1/2 for the metabolism of both mirodenafil and SK3541.
    Choi YH, Lee YS, Lee MG, Kim TK, Lee BY.
    J Pharm Pharm Sci; 2010 Aug 01; 13(1):93-106. PubMed ID: 20456834
    [Abstract] [Full Text] [Related]

  • 10. Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous torasemide in rats.
    Lee DY, Lee SJ, Lee MG.
    Int J Pharm; 2005 Jul 14; 298(1):38-46. PubMed ID: 15890479
    [Abstract] [Full Text] [Related]

  • 11. Effects of enzyme inducers or inhibitors on the pharmacokinetics of intravenous parathion in rats.
    Hurh E, Lee E, Lee A, Kim Y, Kim S, Kim S, Lee M.
    Biopharm Drug Dispos; 2000 Jul 14; 21(5):193-204. PubMed ID: 11180198
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of 5-fluorouracil in mutant Nagase analbuminemic rats: faster metabolism of 5-fluorouracil via CYP1A.
    Choi YH, Bae SK, Kim SO, Lee MG.
    Biopharm Drug Dispos; 2007 Mar 14; 28(2):87-95. PubMed ID: 17230597
    [Abstract] [Full Text] [Related]

  • 13. Metabolism of territrem B and C in liver microsomes from 14-wk-old Wistar rats is catalyzed by cytochrome P-450 3A.
    Peng FC, Chen PC, Jeng YJ, Edwards RJ.
    J Toxicol Environ Health A; 2005 Feb 27; 68(4):299-314. PubMed ID: 15799453
    [Abstract] [Full Text] [Related]

  • 14. Effects of enzyme inducers and inhibitor on the pharmacokinetics of intravenous 2-(allylthio)pyrazine, a new chemoprotective agent, in rats.
    Bu S, Kim Y, Kim S, Lee M.
    Biopharm Drug Dispos; 2000 May 27; 21(4):157-64. PubMed ID: 11180194
    [Abstract] [Full Text] [Related]

  • 15. In vivo cimetidine inhibits hepatic CYP2C6 and CYP2C11 but not CYP1A1 in adult male rats.
    Levine M, Law EY, Bandiera SM, Chang TK, Bellward GD.
    J Pharmacol Exp Ther; 1998 Feb 27; 284(2):493-9. PubMed ID: 9454789
    [Abstract] [Full Text] [Related]

  • 16. Suppression of rat hepatic cytochrome P450s by protein-calorie malnutrition: complete or partial restoration by cysteine or methionine supplementation.
    Cho MK, Kim YG, Lee MG, Kim SG.
    Arch Biochem Biophys; 1999 Dec 01; 372(1):150-8. PubMed ID: 10562428
    [Abstract] [Full Text] [Related]

  • 17. Effects of bacterial lipopolysaccharide on the pharmacokinetics of metformin in rats.
    Choi YH, Lee I, Lee MG.
    Int J Pharm; 2007 Jun 07; 337(1-2):194-201. PubMed ID: 17275228
    [Abstract] [Full Text] [Related]

  • 18. Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous DA-8159, a new erectogenic, in rats.
    Kim YC, Shim HJ, Lee JH, Kim SH, Kwon JW, Kim WB, Lee MG.
    Biopharm Drug Dispos; 2005 Sep 07; 26(6):233-41. PubMed ID: 15926192
    [Abstract] [Full Text] [Related]

  • 19. Effects of neostigmine on the pharmacokinetics of intravenous parathion in rats.
    Hurh E, Lee EJ, Kim YG, Kim SY, Kim SH, Kim YC, Lee MG.
    Res Commun Mol Pathol Pharmacol; 2000 Sep 07; 108(3-4):261-73. PubMed ID: 11913717
    [Abstract] [Full Text] [Related]

  • 20. Metabolite complex formation of orphenadrine with cytochrome P450. Involvement of CYP2C11 and CYP3A isozymes.
    Roos PH, Mahnke A.
    Biochem Pharmacol; 1996 Jul 12; 52(1):73-84. PubMed ID: 8678911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.